RARA CRAFT DATABASE for FDA Medical Devices
510(k)K173127

FDA DEVICE FACTS

skyla Hi Hemoglobin A1c System (skyla Hi Analyzer and skyla Hi Hemoglobin A 1 c Reagent Kit)

Skyla Corporation H.S.P.B

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATESeptember 25, 2018PRODUCT CODELCP

Indications for use

Intended for the quantitative measurement of the percent concentration (%) of glycated hemoglobin (HbA1c %) in venous and finger-stick capillary whole blood. The measurement of % HbA1c is used to monitor long-term glycemic control in persons previously diagnosed with diabetes mellitus. Same Intended users Laboratory professionals and point-of-care users Same Sample type Whole blood: finger-stick capillary and venous Same Method of Sampling Blood is collected with a capillary tube in the reagent pack, and the sampling device Same Similarities Item Candidate Device skyla Hi Hemoglobin A1c System System (skyla Hi Analyzer and skyla Hi Hemoglobin A1c Reagent Kit) (k173127)

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 26, 2026